Our cancer researchers are investigating the molecular basis of the disease including sarcoma, melanoma, mesothelioma, breast, colorectal, prostate and biliary tract cancer.
Using model systems, protein and DNA-based technologies and imaging, they are developing new approaches and therapeutic targets to improve clinical diagnosis and treatment.
A close relationship with the Olivia Newton-John Cancer Research Institute enhances bench-to-bedside outcomes.
To understand the molecular mechanisms of cancer including processes that lead to abnormal cell growth.
To identify new treatment strategies with improved efficacy and fewer side effects.
To develop new technologies for imaging and monitoring cancer progression, and to identify new biomarkers for diagnostic purposes.